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The ovine adenovirus isolate OAV287 represents a new group of adenoviruses that are distinct from the Mast- and
Aviadenoviruses by several criteria, including genome arrangement. The OAV major late promoter and some late transcripts
were previously mapped. To better define the probable coding sequences and to identify the approximate location of early
promoters a partial transcription map of the genome was elucidated using a PCR-based approach. This was possible
because the complete nucleotide sequence of the genome was known. The strategy permitted the identification of
transcription start sites and RNA splice junctions and allowed the approximate location of promoters in the lefthand end, IVa2,
E2, P32K, and E4 regions to be deduced. The data showed that lefthand end and E4 regions are controlled by three and two
temporally distinct promoters, respectively. The E2 region is controlled by a single promoter, in contrast to Mastadenovi-
ruses, where E2 expression is controlled by the E2A and E2B promoters. The p32kDa structural protein at the lefthand end
and the IVa2 protein are also expressed from their own promoters. These data contribute to the first overview of transcription
from a non-Mastadenovirus genome. © 1998 Academic Press
INTRODUCTION
The Adenoviridae have previously been considered to
consist of two genuses, Mastadenovirus (including all
known human and most mammalian viruses) and Avia-
denovirus (typified by CELO virus) (Norrby et al., 1976).
More recently, a third group of adenoviruses (Ad) (as yet
unnamed) was identified by phylogenetic analysis of viral
protease genes. This group includes bovine Ad7, egg
drop syndrome (EDS), and an ovine Ad (OAV287)
(Harrach et al., 1997). The OAV (Vrati et al., 1995, 1996a,
b) and EDS genomes (Hess et al., 1997) have now been
sequenced and compared with other viruses, including
Ad2 (Roberts et al., 1984) and CELO virus (Chiocca et al.,
1996), the prototype Mast- and Aviadenoviruses, respec-
tively.
The genome of Ad2 is divided into five early transcrip-
tion units, ElA/B, E3, E4, driven by individual promoters,
E2, controlled by the E2A and E2B promoters, and one
late transcription unit that is controlled by the major late
promoter (MLP). From each promoter, RNA polymerase II
generates families of transcripts which are modified by
extensive splicing. In addition, there are two delayed
early transcription units, IVa2 and IX, that are also con-
trolled by their own promoters. The E1, IX, MLP, and E3
units are transcribed from left to right on the top strand of
the genome, while the E4, E2, and IVa2 units are tran-
scribed from right to left on the opposite strand, in that
order, respectively. Among the Mastadenoviruses, one or
two VA RNA genes may also be located on the top strand
between the 52/55K and terminal protein genes (re-
viewed in (Horwitz, 1990; Shenk, 1996).
Comparison of the genomes of OAV (Vrati et al., 1995,
1996a, b), CELO (Chiocca et al., 1996), and Ad2 (Roberts
et al., 1984) reveals that each virus group has a genome
structure that is distinct and characteristic. The central
core of each genome, flanked by the IVa2 and fiber
genes, contains sequences that encode the majority of
structural proteins and the DNA replication proteins, but
the left- and righthand ends (LHE, RHE) have open read-
ing frames that are unique to each group. OAV lacks a
typical E1A/E1B region (as defined by the Mastadenovi-
ruses) at the LHE, and has a putative E4 region that is
penultimate in the genome to a group of reading frames
of unknown function. These are located at the RHE on
the bottom strand. Both the E4 and RHE regions appear
to be independent transcription units (Vrati et al., 1996b;
Xu et al., 1997). In addition, OAV lacks sequences coding
for protein IX and core protein V. However, a new struc-
tural protein that appears to require its own promoter is
encoded on the bottom strand at the LHE of the genome
(Vrati et al., 1996b). Consequently, the transcription maps
established for the Mastadenoviruses (reviewed in (Hor-
witz, 1990) will differ from the other two groups, particu-
larly for the regions encoding nonstructural proteins. We
therefore initiated this work to gain an overview of tran-
scription from the OAV genome. This is the first such
work for a non-Mastadenovirus genome.
Because the OAV genome sequence was known, our
strategy to elucidate a transcription map was to reverse
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transcribe RNAs from OAV-infected cells and use primers
to amplify them by PCR. cDNAs were cloned and se-
quenced to identify exons and introns in spliced tran-
scripts and to define probable coding sequences. Addi-
tional analyses were carried out to identify transcription
start sites so that the probable location of promoters in
the OAV genome could be inferred. Temporal expression
from some promoters was also analysed. RNAs from all
transcription units, as well as seven new promoter re-
gions, were identified.
RESULTS
As a general strategy to identify transcripts, primers
that fell within an open reading frame (ORF) were used in
conjunction with upstream primers that were located
near candidate promoters. Alternatively, the ORF primer
was used together with the 59 anchor primer in RACE–
PCR to amplify sequences that included the 59 end of the
RNA. cDNAs were cloned and sequenced to confirm
their identity and to identify exons and introns.
Transcription from the LHE
The revised sequence of the OAV genome (GenBank
Accession Nos. U18755, U31557, U40839, and U40837)
predicts that the first 3 kb at the LHE contains three main
reading frames on the top strand (ORFs LH1, 2, and 3)
which potentially code for proteins of 9.7, 14.7, and 42.8
kDa (Fig. 1A and Table 1), respectively. The bottom
strand is now predicted to code for p32, a precursor
protein of 32.1 kDa (called p28K in Vrati et al., 1996b) (Fig.
1A and Table 1). Inspection of the sequence showed
several polyadenylation signals (AATAAA) 39 to LH1, 2,
and 3 (Table 1) that suggested possible transcript termi-
nation points. Our initial strategy therefore was to use the
59 oligo AK1 (Table 1) together with a 39 primer (AK7, 10,
11) from each of LH1–3 to ascertain whether cDNA
products could be amplified by PCR.
LH1 transcripts
With primers AK1/AK7, two products of ;750 and 550
bp were amplified after 40 cycles of PCR from infected-
cell RNA harvested at 24 h pi (Fig. 1B, lane 5). Sequenc-
ing revealed that they were derived from related, differ-
entially spliced RNAs that were produced from a pro-
moter (LHP1) upstream of base 427. The larger transcript,
LHP1.1, contained sequences that were spliced out in
LHP1.2 (Fig. 1A and Table 1). Both transcripts contained
only one significant ORF that could code for the 9.7-kDa
product. Termination of these RNAs probably occurred at
possible polyadenylation sites at position 1390–1395 or
1467–1471 (Fig. 1A and Table 1) and generally did not
extend into ORF LH2 because little or no such PCR
product was detected using AK1/AK10 or AK1/AK11
primer combinations (data not shown) and because
RACE–PCR with anchor/AK10 did not amplify a product
greater than ;525 bp (Fig. 1C, lane 6) (that corresponded
to LHP2.3, see below). However, AK1/AK10 or AK11 prim-
ers amplified a products of ;600 and 800 bp, respec-
tively. A clone from the latter corresponded to LHP1.3 in
which splicing occurred between position 815 and a new
site at position 1464, i.e., downstream of the polyadenyl-
ation sites (Fig. 1A, Table 1).
To map the cap sites for LHP1.1 and LHP1.2, RACE–
PCR was carried out using the 59 anchor oligo together
with 39 AK7. Major and minor products of ;450 and ;600
bp, respectively, were obtained (Fig. 1C, lane 2) and the
former was cloned. The product at ;170 bp was consid-
ered too short to be a significant transcript. Sequencing
identified clones that carried the expected 59 (anchor
oligo) and 39 terminal (AK7) sequences and confirmed
splice junctions in LHP1.1 and LHP1.2. Unexpectedly,
however, the 59 ends of these clones mapped to posi-
tions 545 and 548 in the genome, i.e., substantially down-
stream of the proposed LHP1 promoter region, suggest-
ing the presence of a second promoter, LHP2 (Fig. 1A
and Table 1). It is possible that the ;600-bp product was
derived from transcripts that originated at the LHP1 pro-
moter.
Temporal analysis of LHP1 and LHP2. To confirm the
presence of two promoters temporal transcription was
investigated semiquantitatively with separate primer
pairs in independent PCR reactions using the same
cDNA prepared from polyadenylated mRNA harvested at
12, 24, and 48 h pi and the same number of PCR cycles.
RNA synthesis from the LHP1 promoter was monitored
by PCR using primers AK1/AK7, a combination that ex-
cluded transcripts from the LHP2 promoter because AK1
was upstream of the LHP2 start sites (Fig. 1A). Products
of ;750 and 550 bp representing LHP1.1 and LHP1.2
transcripts were weakly detectable at 12 and 48 h pi in
some experiments (data not shown) and readily detect-
able at 24 h pi (Fig. 1B, lane 5). Because transcripts
derived from the LHP2 promoter shared sequences in
common with transcripts derived from LHP1, LHP2 tran-
scription could not be monitored exclusively by PCR.
Transcription from both promoters was investigated us-
ing AK3/AK7 primers. An abundant product of ;380 nu-
cleotides was amplified from infected-cell RNA (Fig. 1D,
lanes 3, 5, and 7). The identity of this product was
confirmed by digestion with HpaII, which produced the
expected bands of 200 and 157 bp (data not shown). That
the PCR profile was temporally very different from the
AK1/AK7 profile (Fig. 1B) confirmed the existence of two
promoters in the region. The identification of a single
PCR product (Fig. 1D, lane 3) also suggested that only
the shorter LHP2.2 RNA was produced from LHP2 pro-
moter. A similar temporal profile of LHP2 transcription
was obtained with the AK3/AK10 primer pair (data not
shown).
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LH2 and LH3 transcripts
To identify the 59 ends of transcripts corresponding to
LH2 (14.7 kDa) and LH3 (42.8 kDa), RACE–PCR was
performed using the 59 anchor oligo together with AK10
or AK11. With anchor/AK10 a product of ;525 bp was
obtained (Fig. 1C, lane 6). With anchor/AK11, a product of
;750 bp as well as a shorter product of ;230 bp was
obtained (data not shown). Cloning and sequencing
identified the LH2.3 transcript that contained a new
splice junction at position 1464 and shared upstream
splice junctions with LHP1.1 and LHP1.2 RNAs (Fig. 1A
and Table 1). The 59 ends of five LH2 clones mapped to
positions 540 (three clones), 552, and 567, indicating that
they were also derived from promoter LHP2. Splice junc-
tions in the LHP2.3 family were confirmed by analysis of
AK3/AK10 PCR clones. The 59 ends of the 230-bp (AK11)
clones that contained the appropriate anchor oligo
mapped to positions 1869, 1874, and 1891, indicating the
presence of a third promoter, LHP3, that produced
LHP3.1 transcripts (Fig. 1A and Table 1). These RNAs
FIG. 1. Transcription map of the OAV lefthand end and IVa2 regions. cDNA harvested from uninfected (U) and OAV-infected (I) CSL503 cells at 12,
24, and 48 h pi was reverse transcribed into cDNA using oligo(dT)15 or random primers. Portions of selected RNAs were amplified by PCR or
RACE–PCR using oligonucleotide primers (e.g., AK1, AK7 etc.) as described in the text. PCR products were cloned and sequenced to confirm their
identity and to determine the location of splice junctions. In (A) the relevant portion of the genome is indicated. Predicted ORFs (striped boxes) are
shown above and below the line for the left to right and right to left orientations, respectively. Thick lines represent sequenced regions and thin lines
indicate the likely extent of the transcript terminating with a polyadenylation signal (*). (#) Signifies that transcription start sites were mapped by
RACE–PCR. (M) Indicates the first available Met in the ORF. Transcripts were named according to the promoter from which they were derived and
numbered separately if their splicing pattern differed. The approximate location of promoters LHP1, 2, 3 etc. is indicated by shaded boxes. Arrows
indicate the direction of transcription. The lower panels show PCR analyses that were carried out using the primer pairs indicated. Temporal
transcription from the LHP1 and LHP2 promoters was analysed in B and D. Products that were cloned and sequenced in B and C are marked with
a dot. (,) Signifies a possible LHP1 RACE–PCR product. (∧) Marks the ;380-bp AK3/AK7 product. Inverted images of ethidum bromide-stained
agarose gels are shown. The sizes of marker fragments are indicated.
130 KHATRI AND BOTH
were unspliced and probably terminated following the
polyadenylation site at the end of LH3.
Because a possible polyadenylation site was present
in LH2 at position 1860–1865, PCR was carried out with
AK3/AK11 primers to ascertain whether LHP2.3 tran-
scripts terminated at this point or continued into LH3
(Fig. 1A). A product of ;700 bp was obtained (data not
shown) and sequenced, showing that it was a spliced
transcript and confirming that LHP2.3 transcripts were
extended (Fig. 1A). Similarly, primers AK3/AK13 produced
a PCR product of ;1.6 kb (data not shown), indicating
that LHP2.3 transcripts also terminated at the common
polyadenylation site at 3054–3059, as previously mapped
(Vrati et al., 1996a). Using AK3/AK11 primers a single PCR
clone (LHP.4; Fig. 1A) was also obtained in which the
intron between bases 635 and 743 was retained, while a
longer intron between nucleotides 815 and 1828 was
spliced out. In an attempt to specifically amplify this
transcript from infected-cell RNA, primer AK4, from within
the retained intron, was used together with AK11 (Fig.
1A). However, this combination did not amplify the ex-
pected product of ;400 bp but did produce a product of
;1.4 kb, expected from residual genomic DNA in the
48-h sample (data not shown).
p32k transcripts
The OAV genome also codes for a proteolytically pro-
cessed structural protein on the bottom strand at the
LHE (Vrati et al., 1996b). The revised OAV sequence
(GenBank Accession No. U40839) and peptide data (Vrati
et al., 1996b) predicts that this is a 30.9-kDa protein
derived from a 32.1-kDa precursor (Table 1). To locate the
P32 promoter, RACE–PCR was performed using 59 an-
chor/AK5 primers (Fig. 1A). A virus-specific product of
;340 bp was obtained by nested PCR with AK6. Two
clones of appropriate size that carried the 59 anchor
oligo were identified by sequencing. Neither clone con-
tained an intron and the 59 ends of these P32.1 tran-
scripts mapped to positions 1144 and 1161 on the neg-
ative strand (Fig. 1A and Table 1), suggesting that the
P32 promoter was nearby. No p32k-like clones were
obtained when AK3/AK7 primers were used for PCR,
suggesting that the P32.1 transcript initiated to the left of
the AK7 sequence. A product of 733 bp should have
resulted from amplification of unspliced p32k transcripts
or residual genomic DNA. Some material of this size was
produced (Fig. 1D), but it was not virus specific. Two
putative p32 clones of this size did not contain OAV
sequences. The first initiation codon in ORF p32 oc-
curred 12 amino acids upstream of the previously iden-
tified protease cleavage site (Vrati et al., 1996b).
IVa2 transcripts
The location of the IVa2 promoter was also investi-
gated. Because the IVa2 promoter lies adjacent to the
MLP in Ad2 (Natarajan et al., 1985) it was thought that a
similar situation might exist in OAV. Primers were de-
signed from an analysis of conserved sequences and
possible initiation codons in the vicinity of the MLP. PCR
performed with primers AK15/AK17A (bases 4744–4768)
TABLE 1
Summary of Lefthand End and IVa2 Transcripts
ORF RNA Start sites 59 Exon Exon Exon
Coding
region
Poly(A)
signal Amplified by
LH1 9.7 kDa LHP1.1 (1)a ND ,427-815b 1061. — 1143–1391 1390–1395 or
1467–1471
AK1/AK7c 4271/13182
LH1 LHP1.2 (1) ND ,427-634 744-815 1061.b As above As above AK1/AK7
LH2 14.7 kDa LHP1.3 (1) ND ,427-634 744-815 1464. 1489–1872 3054–3059 AK1/AK11
LH1 LHP2.2 (2) 545, 548 545-634 744-815 1061. 1143–1391 1390–1395 or
1467–1471
RACE/AK7
LH2 14.7 kDa
(E1B 19 kDa)e
LHP2.3 (8) 538, 552,
(3)d (1)
575 (1)
538-634 744-815 1464. 1489–1872 3054–3059 RACE/AK10 18291 and
AK3/AK11 5851/20562
LHP.4 (1) ND ,585-815 1828. 1915–3063 3054–3059 AK3/AK11
LH3 42.8 kDa
(E1B 55 kDa)e
LHP3.1 (3) 1869, 1874,
1891
— — — 1915–3063 3054–3059 RACE/AK11
p32 32.1 kDa P32.1 (2) 1144, 1161 — — — 238–1098
(2 strand)
377–382? AK5/RACE 7231
IVa2 37.5 kDa IVa2.1 (2) 4268, 4273 — — — 3071–4055
(2 strand)
3071–3076 AK15/RACE 37291
a Number of clones analysed to determine splice junctions.
b (,) and (.) signifies that exon begins before or continues beyond the indicated nucleotide, respectively.
c The 59 nucleotide and (1) or (2) sense of the primer is shown at first mention.
d Number of clones analysed to determine start sites.
e Shows homology with the Ad5 protein (Vrati et al., 1996b).
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and AK15/AK40 (bases 4793–4819) (Fig. 1A) amplified a
virus-specific product of ;400 bp that was cloned and
sequenced. Two clones that were derived from spliced
RNAs were identified (data not shown) but they did not
represent IVa2 transcripts. They had a common splice
site at base 3791, well within the IVa2 ORF, different
rightward splice junctions at positions 4488 and 4515,
and a reading frame that was not continuous with the
predicted IVa2 ORF. In fact the clones identified frame-
shifted transcripts that potentially would have coded for
DNA pol with C-terminal truncations. RACE–PCR was
then carried out using the AK15/59 anchor primer com-
bination and the same anchor-modified RNA preparation
that was used to map the E4 and DBP transcription start
sites (see below). The largest product obtained was
;360 bp in size. Two clones were obtained in which the
59 ends mapped to positions 4268 and 4273 (Table 1).
Use of the first available initiation codon 74 residues
downstream would produce a protein of 37.5 kDa.
E2 genes and transcripts
OAV E2 genes coding for DNA binding protein (DBP),
terminal protein (TP), and DNA polymerase (DNA pol)
were clearly identified by their homology with other Ad
genes (Vrati et al., 1996a, b). For Ad2, expression of the
E2 proteins is driven by early promoters E2A and E2B.
These are located between the 33K and pVIII genes and
within the 100K hexon assembly gene, respectively (Hor-
witz, 1990). Comparison of OAV and Ad5 nucleotide se-
quences suggested that OAV promoters might also be
located in these positions.
DBP transcripts
To test this, 59 primers AK31 and AK32 were used in
conjunction with DBP primer AK28. The AK28/AK31 com-
bination failed to amplify a product, but AK28/AK32 pro-
duced an abundant virus-specific band of ;850 bp from
RNA harvested at 12, 24, or 48 h pi (see Fig. 5 of Khatri
et al., 1997). Direct sequencing of the product identified
transcript DBP.1 and its exons. The data were confirmed
by RACE–PCR and sequencing again using 59 anchor/
AK28. The 59 end of a clone identified by this means
mapped to position 21,380, eight bases upstream of
AK32. Thus, DBP.1 has a 59 exon and a second exon of 98
nucleotides upstream of the ORF (Fig. 2A, and Table 2)
and the first Met was located within the DBP ORF (Fig. 2A
and Table 2), predicting a protein of 43.5 kDa. DBP.1
transcripts probably terminate near the first available
polyadenylation signal beyond the ORF at position
17895–17900.
Terminal protein (pTP) transcripts
pTP transcripts were identified by PCR with primers
AK21a/AK32 (Table 2 and Fig. 2A). Virus-specific prod-
ucts of ;750 and ;250 bp were obtained but their ratios
varied with the time pi. The larger product decreased in
amount from 12 to 48 h pi, while the smaller one in-
creased (Fig. 2B, lanes 3, 5, and 7). The larger product
yielded clones of two types, TP.1 and TP.2, that differed in
the number of exons they contained (Fig. 2A and Table 2).
The 59 exons were common, but the third exon in TP.1
was absent from TP.2. TP.1 exon 4 and the splice junction
with the major ORF were again shared with TP.2. The
initiation codon for pTP is not within the major ORF.
Splicing out the last intron before the main ORF linked
the amino acid sequence MTARQ, in the penultimate
exon, in-frame to IHQWQQ at residue 65 of the major
ORF (Fig. 2A).
Clone TP.3, derived from the short PCR product pro-
duced at late times pi (Fig. 2B, lanes 5 and 7), had a
longer 59 exon (Table 2). Splicing apparently occurred
between the sequence TGGATATTTTT at position 21,263
on the minus strand to the same sequence (underlined)
at position 8654 in the TP ORF, creating an mRNA with
the sequence TGGATAGAATAT. The first available Met in
the new transcript occurred a further 10 residues down-
stream of the junction and formed part of a potential
protease cleavage site, i.e., MQGF’G. TP transcripts
probably terminate near the polyadenylation signal at the
end of the ORF at position 7344–7349 (Fig. 2A).
DNA pol transcripts
DNA pol transcripts were identified by PCR with prim-
ers AK19/AK32 (Fig. 2A). A virus-specific product of ;800
bp was amplified at 12 h pi. At 24 and 48 h many other
virus-specific products were produced (data not shown),
some of which appeared to be amplified from late RNAs.
These obscured the DNA pol-specific product. The
800-bp product corresponding to DNA pol.1 contained
three exons, all of which were common to TP.2 tran-
scripts (Fig. 2A and Table 2). The initiating Met was
within the major ORF. DNA pol transcripts probably ter-
minate at the first available polyadenylation signal at the
end of the ORF for IVa2 at position 3071–3076.
E4 transcripts
The revised genome sequence (GenBank Accession
No. U40838) now shows that the putative E4 region
comprises three major ORFs, potentially coding for pro-
teins of 17.1 kDa (E41), 25.6 kDa (E42), and 30.85 kDa
(E43) (Fig. 3 and Table 3). Because the location of the
promoter for this region was unknown, primers AK34,
AK35, and AK36 from each of the ORFs (Fig. 3A and Table
3) were used in RACE–PCR analyses to map the 59 ends
of E4 transcripts. The largest virus-specific product that
was detected with RACE/AK34 was ;300 bp in size (Fig.
3B, lane 3). This yielded two types of clones with the
correct terminal anchor/primer sequences (P1E43.1 and
P2E43.1). The clones shared downstream exons and
splice junctions but differed in their 59 exons with tran-
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scription start sites being located at positions 26,030 and
26,251 (Fig. 3A and Table 3). This suggested the pres-
ence of two separate promoters, P2E4 and P1E4, respec-
tively, within the ;1-kb A/T-rich region of the genome
that was previously of unknown function (Vrati et al.,
1996b). RACE–PCR amplification with primers AK36 and
AK35 produced virus-specific products of ;420 and
;520 bp, respectively (Fig. 3B, lanes 6 and 8). However,
only clones with 59 ends that mapped between positions
25,985 and 26,039, i.e., to the P2E4 promoter, were ob-
tained, e.g., P2E41.1 and P2E42.1 (Fig. 3A and Table 3).
Temporal analysis of E4 promoters
To confirm the existence of two promoters, new prim-
ers from within the 59 exons were made (AK37 and AK39;
Table 3 and Fig. 3A) and used for PCR in conjunction with
the downstream primers AK33, AK35, and AK36, using
the same cDNA preparations and the same number of
PCR cycles. Products were amplified from P2E4 RNAs
harvested at 12, 24, or 48 h pi with AK33/AK37 (Fig. 3C,
lanes 3 and 5 and data not shown), AK35/AK37, and
AK36/AK37 (data not shown). In general, these clones
had the same exons and splice junctions as the clones
above isolated by RACE–PCR, although some variations
were noticed. For example, in P2E41.2 the intron between
exons 3 and 4 was retained (Fig. 3A and Table 3). How-
ever, no detectable virus-specific products were ampli-
fied when the P1E4 primer AK39 was used with E41 and
E42 primers AK35 and AK36 (data not shown), suggest-
ing that E41 and E42 RNAs were not expressed from the
P1E4 promoter and that the P1E4 promoter may only
function at early times to generate E43 transcripts. In
contrast, PCR with primers AK33/AK39 generated prod-
ucts of ;500 and ;700 bp from RNA harvested at 12 h
pi, but not at later times (Fig. 3D, lanes 3 and 5). (The
product of ,235 bp (lane 3) was considered too short to
FIG. 2. Transcription map of the OAV E2 region. Details of nomenclature are as for Fig. 1. The E2 promoter and transcripts for DBP, pTP, and DNA
pol are indicated. The probable initiation codon for pTP lies outside the main ORF. (B) Temporal PCR analysis of pTP transcripts using primers
AK21a/AK32. The ;760- and ,235-bp fragments yielded clones corresponding to transcripts TP.1/2 and TP.3, respectively.
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be significant given the location of the AK33 primer at the
39 end of ORF E43.) A fragment of ;2000 bp, probably
amplified from residual viral DNA, was observed at 48 h
pi (Fig. 3D, lane 7). The 59 exons of P1E43.2 and P1E43.3
were differentially spliced, although they shared a down-
stream exon and splice junctions (Fig. 3A and Table 3).
The temporal comparison of P1E4 and P2E4 promoter
function using AK33/AK37 and AK33/AK39 primer pairs
showed clearly that P1E4 functioned only at early
times while P2E4 also functioned at later times (Figs. 3C
and 3D).
Early transcripts from the MLP
During Ad2 infection, the major late promoter is active
at early times but the splicing pattern of early L1 tran-
scripts differs from that of late transcripts which have the
characteristic tripartite leader sequence (TLS) (reviewed
in (Horwitz, 1990). To ascertain whether a similar change
in splicing pattern occurred during OAV infection, PCR
was performed using a primer from within TLS exon 1
(AK18) and AK23, located in the OAV 38.2-kDa ORF (Fig.
4 and Table 4). PCR products amplified from RNA har-
vested at 12, 24, and 48 h pi differed greatly. A minor
product of ;1400 bp was identified at 12 and 24 h pi,
while a major product of ;500 bp was present at 24 h
and to a lesser extent at 48 h pi (Fig. 4B, lanes 3, 5, and
7). An additional minor product of ;800 bp was also
detected at 24 h pi. Clones of the ;1400- and ;500-bp
fragments were obtained and sequenced. Most of the
500-bp clones were derived from MLP L1.2 and con-
tained the previously described OAV TLS (Vrati et al.,
1996a), but a variant (MLP L1.3) that lacked exon 2 was
also identified (Fig. 4, Table 4). The 1400-bp fragment
was derived from MLP L1.1 transcripts that lacked an
intron following what is exon 3 in L1.2. The initiation
codon of the 38.2-kDa ORF was unchanged.
DISCUSSION
OAV is distinguishable from the Mast- and Aviadeno-
viruses by several criteria. Phylogenetic analysis of the
protease and hexon genes groups OAV with BAV-7 and
EDS viruses (Harrach et al., 1997; Hess et al., 1997). In
addition, the distinctive genome arrangement and high
A/T content of OAV, the presence of at least one unique
viral capsid protein and the absence of others, and the
characteristics of its nonstructural proteins (Vrati et al.,
1995; Vrati et al., 1996b; Xu et al., 1997) separate OAV
from other genuses of the Adenoviridae. This was re-
cently confirmed by analysis of the related EDS genome
(Hess et al., 1997). Therefore, the location of promoters
controlling transcription units in OAV could not be readily
deduced by comparisons with Mastadenoviruses, the
only viruses for which data were available (reviewed in
(Horwitz, 1990). Some data describing late transcripts
and early RNAs from the RHE of OAV were obtained
TA
B
LE
2
S
um
m
ar
y
of
E
2
Tr
an
sc
ri
pt
s
O
R
F
R
N
A
P
ol
y(
A
)
si
gn
al
C
od
in
g
re
gi
on
E
xo
n
E
xo
n
E
xo
n
E
xo
n
59
E
xo
n
A
m
pl
ifi
ed
by
D
B
P
43
.5
kD
a
D
B
P
.1
a
17
89
5–
17
90
0
17
96
4–
19
11
3
,
19
14
2
—
—
19
46
0–
19
55
8
21
31
8-
.
21
37
2
21
38
0c
A
K2
8/
A
K3
2b
18
30
11
/2
13
72
2
A
K/
28
/R
A
C
E
pT
P
69
.8
kD
a
TP
.1
(3
)d
(e
ar
ly
)
73
44
–7
34
9
73
48
–9
12
0
,
91
20
11
88
1–
11
98
9
16
44
8–
16
51
0
19
46
0–
19
55
8
21
31
8-
.
21
37
2
A
K2
1a
/A
K3
2
86
15
1
TP
.2
(1
)
,
91
20
11
88
1–
11
98
9
—
19
46
0–
19
55
8
21
31
8-
.
21
37
2
TP
49
.6
kD
a
TP
.3
(4
)
(la
te
)
73
48
–8
61
9
,
86
47
—
—
—
21
25
8-
.
21
37
2
D
N
A
po
l1
25
.3
4
kD
a
D
N
A
po
l.1
(1
)
30
71
–3
07
6
41
51
–7
36
5
,
75
74
11
88
1–
11
98
9
—
19
46
0–
19
55
8
21
31
8-
.
21
37
2
A
K1
9/
A
K3
2
69
58
1
a
P
C
R
pr
od
uc
t
in
iti
al
ly
se
qu
en
ce
d
di
re
ct
ly
,i
.e
.,
no
t
cl
on
ed
.
b
S
ee
Ta
bl
e
1,
no
te
C
.
c
D
B
P.
1
st
ar
t
si
te
de
te
rm
in
ed
fo
r
on
e
cl
on
e.
d
C
lo
ne
s
se
qu
en
ce
d
to
de
te
rm
in
e
sp
lic
e
ju
nc
tio
ns
.
134 KHATRI AND BOTH
previously (Vrati et al., 1995, 1996a; Xu et al., 1997). To
gain an overview of transcription in OAV, a PCR-based
strategy was used to identify early transcripts and their
splice junctions as well as the 59 ends of RNAs. This
achieved a better definition of probable reading frames
in the genome and defined the likely location of viral
promoters.
Several points were considered in relation to the PCR
strategy. Firstly, the 59 ends of transcripts were mapped
by RLM–RACE and RT–PCR in an attempt to identify the
locations of promoters in the genome. This procedure
was selected to minimise the detection of truncated
RNAs. Only capped transcripts that retained a 59 phos-
phate after alkaline phosphatase/pyrophosphatase treat-
ment were capable of accepting the anchor oligonucle-
otide during ligation (Maruyama and Sugano, 1994). Only
in the event that the 59 end of an RNA was unavailable for
ligation would a species not be represented in the pop-
ulation. As a further safeguard against truncation, only
full-length cDNA molecules in which the anchor se-
quence was copied by reverse transcriptase could then
be amplified by PCR using the anchor oligo in combina-
tion with a downstream primer. The discrete nature of
RACE–PCR products that we obtained coupled with RT–
PCR analyses of GAPDH in the RNA samples (see Ma-
terials and Methods) argues that the transcripts anal-
ysed in these studies were intact. Secondly, to overcome
the imperfect specificity of primer pairs in some PCR
reactions, apparent virus-specific products were cloned
and positively identified by nucleotide sequencing. Com-
parisons against the known genomic sequence of OAV
(Vrati et al., 1995, 1996a, b) identified splice junctions
within transcripts. PCR profiles were used only to dem-
onstrate temporal differences in promoter function.
Thirdly, PCR amplification may not have resulted in the
quantitative detection of all potential products. Single
primer pairs were used in all PCR reactions to amplify
families of related transcripts. However, the data may not
reflect the relative abundance of transcripts from a given
promoter, nor were all differentially spliced transcripts
necessarily identified. Lastly, the location of transcription
start sites identified for LHP2 and E4P2 transcripts were
FIG. 3. Transcription map of the OAV E4 region. The nomenclature is described in Fig. 1. Promoters P1E4 and P2E4 and the transcripts derived from
them are indicated. RACE–PCR (B) and temporal analysis of selected P2E4 (C) and P1E4 (D) transcripts were carried out using the primer pairs
indicated.
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more widespread than observed for TATA-element con-
taining Ad2 promoters in an earlier study (Baker and Ziff,
1981). However, with improved cDNA cloning procedures
similar to those used in our work a wider distribution of
cap sites has been found for a large variety of tran-
scripts, particularly when polypyrimidine tracts occurred
just upstream (Kato et al., 1994). Polypyrimidine tracts
that are located 59 proximal the cap sites for LHP2 and
E4P2 promoters may influence the initiation of transcrip-
tion.
Transcription units in the genome
There appear to be seven transcription units in the
OAV genome controlled by 10 promoters. For the P32,
IVa2, E2, and RHE units individual promoters appear to
control expression. The surprising observation was that
for the LHE three promoters appear to control the tran-
scription of three ORFs. The LHP1 promoter appears to
be genuine, rather than an infrequent, alternative pro-
ducer of related transcripts (Osborne et al., 1982) be-
cause it functioned in a temporally distinct manner. Sim-
ilarly, dual E4 promoters apparently exist, as defined by
the identification of RACE–PCR transcripts with common
downstream sequences and distinct 59 exons. These
promoters also appeared to operate at different times
during infection in permissive CSL503 cells as identified
by their temporally distinct PCR profiles (Table 5). Al-
though the PCR analyses were not quantitative, at a
gross level, based on amplification of the same cDNA
preparation for the same number of cycles, the LHP2 and
P2E4 promoters were more active than the LHP1 and
E4P1 promoters, respectively.
LHE transcription
The LHE of the genome potentially codes for three
proteins on the top strand and one structural protein on
the bottom strand (Fig. 1A). The OAV LH2 and LH3 ORFs
show limited homology with the E1B proteins of Ad2 (19
and 20% identity for LH2 and LH3, respectively, when
aligned by standard GCG parameters described in Vrati
et al., (1996b) but are closer to their EDS homologues (29
and 35% identity, respectively). Similarly, the p32
polypeptide has an EDS counterpart (Vrati et al., 1996b;
Hess et al., 1997). LH1 shows no detectable homology
with any other Ad. RNAs coding for the LH1 product were
transcribed from either the LHP1 or LHP2 promoters but
appeared not to extend beyond the polyadenylation sig-
nals at the end of this ORF as judged by the RACE–PCR
products (Fig. 1C) and because AK1/AK10 or AK11 primer
combinations failed to produce a PCR product of a size
consistent with a continuous transcript. Similarly, tran-
scripts for LH2 were detected from both promoters,
and these probably continued through ORF LH3. LHP3.1
RNAs apparently originated from the LHP3 promoter lo-
cated between the LH2 and LH3 ORFs, because cap
sites that mapped between positions 1870 and 1892
were identified by RACE–PCR. There is no strong candi-
date TATA box upstream of these start sites.
A clone that represented transcript LHP.4 (Fig. 1A),
derived from the LHP1 or LHP2 promoters, was amplified
with primers AK3 and AK11. Potentially, this transcript
could have represented the major transcript for LH3,
spliced so that the first Met in the LH3 was the initiation
codon. This would have removed the need for an LHP3
promoter. However, LHP.4 contained a splice junction at
position 1828, a site that was not predicted from the OAV
TABLE 3
Summary of E4 Region Transcripts
ORF
Promoter
transcript
Coding
region Exon Exon Exon Exon 59 Exon Amplified by
E43 30.85 kDa
(E4/34K
protein)a
P1E43.1 23851–24564 ,24593 25731–25752 25838–25878 26213-26251b (1)c AK34-RACE
d
244191
AK33/AK39
242201/262372
P1E43.2 ,24593 25731–25752 25838–25878 25965-.26237 (1) AK33/AK39
P1E43.3 ,24593 25731–25752 25838–25878 25965–26043 26213-.26237 (1) AK33/AK39
P2E43.1 ,24593 25731–25752 25838–25878 25965-26030 (1) AK34-RACE
E42 25.6 kDa
(E4/34K
protein)a
P2E42.1 24561–25233 ,25238 25731–25752 25838–25878 25965-25933,
26039 (4)
AK35-RACE 248261
AK35/AK37 25989-
E41 17.1 kDa P2E41.1 25223–25651 ,25651 25731–25752 25838–25878 25965-25985 (2) AK36-RACE 253251
AK36/AK37
P2E41.2 ,25651–25752 25838–25878 25965-25993 (5) AK36-RACE AK36/AK37
a Shows limited homology with Ad2 ORF6 34-kDa protein (Vrati et al., 1996b).
b Underlined numbers signify one or more cap sites determined.
c Clones analysed to determine splice junctions.
d See Table 1, note C.
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genome sequence because an AC9GT, rather than an
AG9GT sequence was present. LHP.4 also retained an
intron between bases 635 and 743 (Fig. 1A). Using se-
quences in this intron, PCR amplification was performed
to selectively amplify the transcript. However, no product
of the expected size was obtained. Therefore it is con-
cluded that the LHP.4 clone represented an atypical
transcript and that LH3 RNAs are derived from LHP3,
rather than an upstream promoter.
The transcription map (Fig. 1A) derived by the PCR
strategy agreed with an analysis of LHE RNAs by North-
ern hybridisation. Using a probe that spanned the first
FIG. 4. Transcripts and leader sequences from the major late promoter. In A the differentially spliced transcripts coding for the 38.2-kDa protein
are shown. In (B) a PCR analysis using primers AK18/AK23 produced virus-specific products of ;1400 bp (lane 3) and ;500 bp (lanes 3 and 5). These
were cloned and sequenced to identify the early and late leader sequences shown in (A).
TABLE 4
Summary of MLP Transcripts
ORF RNA 59 Exon Exon Exon Exon
Coding
region
Poly(A)
signal Amplified by
38.2 kDa
(52/55K)a
L1.1 (2)b 5013–5133 8082–8144 8349–9158. 9158–10165 11862–11867 AK18/AK23c
50131/95222
L1.2 (4) 5013–5133 8082–8144 8349–8411 9158. AK18/AK23
L1.3 (1) 5013–5133 — 8349–8411 9158. AK18/AK23
pIIIa 58.4 kDa 10099. 10316–11863 11862–11867 Vrati et al. (1996a)
a Shows homology with the Ad5 protein (Vrati et al., 1996a,b).
b Number of clones sequenced to determine splice junctions (see also Vrati et al., 1996a).
c See Table 1.
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2.5 kb of the genome, RNAs of ;0.6 kb were detectable
as early as 8 h pi and at 24 h pi additional species of
;1.4 and ;2 kb were present (Z. Z. Xu, unpublished
results). These sizes agree well with those predicted
from Fig. 1A. In particular, because the LHP3.1 transcript
was expected to be ;1.4 kb in size (Fig. 1A), its appear-
ance at a time distinct from the smaller LHP2 products
confirmed the existence of the LHP3 promoter.
It is also of interest that LHP2.3 RNAs continued into
the LH3 ORF, probably terminating at a common point
downstream (Fig. 1A). Such an arrangement is consis-
tent with transcription of the Ad5 genome where
readthrough transcription from the upstream E1A region
provided a cis-acting effect that relieved repression of
the E1B promoter prior to DNA replication (Maxfield and
Spector, 1997). The structural protein p32K also has its
own promoter and produces an unspliced transcript. In
both senses it is similar to protein IX production by
Mastadenoviruses.
IVa2 promoter
Because the IVa2 promoter is adjacent to the MLP in
Ad2 (Natarajan et al., 1984), attempts were also made to
identify upstream transcription start sites by comparing
OAV MLP sequences with Ad2. The region also codes for
the highly conserved DNA pol, which made it possible to
deduce the theoretical position of the IVa2 transcription
start site in OAV and identify a nearby AT-rich motif
TATAAAAA (Chen et al., 1994). However, PCR products
amplified with AK15 and two primers from this region did
not identify spliced RNAs that were linked to the IVa2
reading frame, although clones that potentially modified
the C-terminus of DNA pol were identified. The latter
most probably represented unproductive splicing events
similar to others identified for pVIII RNAs in previous
work (Vrati et al., 1995), although analysis of DNA pol
itself is required to determine whether the enzyme is
modified during infection.
The IVa2 promoter region was subsequently identified
by RACE–PCR. The transcription start sites for the largest
product mapped ;130 bases into the ORF. The results
are supported by the fact that the start sites were iden-
tified using the same anchor-modified RNA preparation
that was used to map the LHP2 and E4 start sites and
promoters. If the location of the IVa2 promoter is con-
firmed by other means, its location would suggest that
the IVa2 transcripts are unspliced. The initiation codon
located ;74 residues downstream of the start sites was
the first available in the ORF. Initiation at this point would
produce a protein of 37.5 kDa. This is shorter than the
theoretical IVa2 protein of EDS which has a Met codon
that is absent from OAV (Vrati et al., 1996a; Hess et al.,
1997). The next available Met in EDS occurs past the end
of the overlapping DNA pol ORF near the proposed
initiation site for OAV and would produce a protein of 36.1
kDa. The N-terminal portions of IVa2 from CELO, EDS/
OAV, and Ad2/Ad40, representing the three genera, differ
in length and show little homology compared with down-
stream sequences from residue ;150 of Ad2 to the
C-terminus, which are substantially conserved. However,
the shorter EDS and IVa2 proteins contain all the con-
served sequences (Fig. 5).
Control of E2 transcripts
For the E2 transcription unit there was a distinct dif-
ference in control between the Mastadenoviruses and
OAV. During Ad2 infection DBP expression at early times
is controlled by the E2A promoter, located between the
33K and pVIII ORFs, while at later times DBP, pTP, and
DNA pol are expressed from the E2B promoter in the
100K ORF. Thus, TP and DNA pol are not expressed from
E2A (reviewed in (Horwitz, 1990; Shenk, 1996). For OAV, a
single promoter located between the 33K and pVIII ORFs
appeared to control expression of the whole region be-
cause we identified transcripts for pTP and DNA pol that
were derived from the same promoter as DBP. The initi-
ating methionine for DBP and DNA pol apparently re-
sides within the respective major ORF, but for pTP it was
located in the penultimate exon (Fig. 2A). Thus, the TP
coding region (69.8 kDa) is shorter than was previously
thought (Vrati et al., 1996a, b).
A distinct change in the processing pattern for pTP
transcripts was also observed during infection, suggest-
ing that alternative RNA splicing and processing may be
used to produce a shorter form of pTP later in the infec-
tious cycle. A splicing event that linked an extended 59
exon directly to residue 220 in the major ORF eliminated
upstream methionines and positioned Met231 as the first
initiation codon, suggesting the production of a truncated
form of pTP with the N-terminal sequence MQGF9G. This
sequence is also a site for processing of pTP to iTP by
the viral protease (Webster et al., 1994). However, the
sequence across the splice junction of these clones
(TGGATAGAAT; 59 exon sequence underlined) did not
TABLE 5
Summary of OAV Promoter Activity
Promoter
Time pi (h)
12 24 48
LHP1 2 1 1
LHP2 1 1 1
LHP3a 2 1 nd
E2b 1 1 1
P1E4 1 2 2
P2E4 1 1 1
RHEb 1 1 1
a Based on Northern analysis (Z. Xu, unpublished results).
b Khatri et al. (1997).
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conform to major (GT-AG) or minor (AT-AC) splice se-
quences (Kreivi and Lamond, 1996). Thus, the derivation
of this transcript is unclear.
E4 region transcription
E4 transcripts with distinct 59 exons identified two
promoters that lie within ;1 kb of A/T-rich sequences
whose function was previously unknown (Vrati et al.,
1996b). The promoters may have different levels of ac-
tivity, with P2E4 . P1E4. The P2E4 promoter was active
at 12 h and throughout infection (Table 5) and produced
transcripts for all three E4 ORFs. In contrast, P1E4 activ-
ity was detectable at 12 h but not at 24 or 48 h pi and only
transcripts that coded for ORF E43 appeared to be pro-
duced. This ORF potentially codes for a protein that has
some homology to the Mastadenovirus E4 34-kDa pro-
tein (Vrati et al., 1996b). Further work is required to
ascertain whether the P1E4 promoter is one of the ear-
liest active promoters during infection.
L1 transcripts from the MLP
Products transcribed from the OAV MLP at early times
were clearly distinct from those produced late in infec-
tion. At 12 h a much longer transcript was produced in
which the intron separating TLS exon 3 from the 38.2-
kDa ORF was retained. By 24 h pi, when late transcrip-
tion was in progress, the dominant product was the
shorter RNA that carried the TLS (Vrati et al., 1996a) or a
variant of it (Fig. 4). The longer transcript contains a
leader that may be the equivalent of the ‘‘i’’ leader that
was described for Ad2 early L1 transcripts (Alestrom et
al., 1982).
OAV promoter regions
The locations of the promoters described in this work
are approximate and should be confirmed by more de-
tailed studies of individual transcription units. Neverthe-
less, inspection of the sequences near the transcription
start sites reveals features consistent with the presence
of promoters. Possible TATA box (TTAAAA) and CAT
boxes (CAAT) are located 30–40 and ;100 nucleotides,
respectively, upstream of LHP2.2 transcription start sites.
The sequences tGGAAtTtACA and AGGAAGgGcCA are
present in the OAV genome at nucleotides 64 and 277,
respectively. These motifs are similar to the duplicated
enhancer sequence described for the Ad2 E1A region
(Hearing and Shenk, 1983) and could influence transcrip-
tion from the LHP2 promoter that may lie in the region of
nucleotides 455–515. The location of the LHP1 promoter
has not been determined, but it could conceivably lie
within the 46-bp inverted terminal repeat sequence,
where an ATATATAA sequence and a possible SP1 tran-
scription factor binding site, GGGCGtG, are present. Sim-
ilarly, at the RHE the promoter may also incorporate the
ITR sequence because there are no other candidate
TATA box sequences between the ITR and the first Met,
which is located only 117 nucleotides from the end of the
genome. Alternatively, these promoters might lack TATA
box sequences. For the P32 promoter a TATA box is
found ;80 nucleotides upstream of the P32.1 transcrip-
tion start site and a CAT box is present ;60 nucleotides
FIG. 5. Comparison of the amino-terminal regions of IVa2 proteins. Sequences for Ad2, Ad40, CELO, EDS, and OAV are compared. Sequence identity
between the genera is indicated by the boxed regions. A similar degree of identity extends to the C-terminus of the proteins. In the OAV sequence,
triangles indicate the location of cap sites, the vertical bar shows the end of DNA pol in the overlapping ORF. Potential initiating methionine residues
downstream of the DNA pol ORF are underlined.
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further upstream. The Ad2 IVa2 promoter has an initiator
sequence and a downstream TATA element (Carcamo et
al., 1991; Chen et al., 1994). For the OAV IVa2 promoter
region there are possible TATA elements 90 and ;140
nucleotides upstream of the start sites. Other features in
the proposed promoter region are not readily identifiable
and other studies will be required to locate it more
precisely. The E2 promoter region contains a TATA box
;25 nucleotides from the transcription start site and may
contain binding sites for ATF and SP1 transcription fac-
tors but apparently lacks a binding site for E2F, a tran-
scription factor that is important in controlling expression
of this region during Ad2 infection. In the E4 region,
classic TATA box motifs are present 50 nucleotides up-
stream of the E4P1 start site and very close to the start
sites for E4P2 transcripts. For the latter, the Ad2 E1A
enhancer motif AGGAAGTtAaA is also present nearby.
This is consistent with the apparent greater strength of
the E4P2 promoter. These observations encourage more
detailed studies to define promoter regions by subclon-
ing/reporter gene expression and footprint analyses.
More detailed temporal studies are also need to define
the promoter(s) that is activated immediately after infec-
tion.
Comparison with EDS
In the proposed third virus group, EDS is the only other
member for which the complete nucleotide sequence
has been determined (Hess et al., 1997). The elucidation
of the OAV transcription map highlights features of the
two genomes that merit brief comment. At the LHE, EDS
has no reading frame that matches the OAV 9.7-kDa ORF,
although other ORFs, including a P32K homologue are
present. In the E2 region, the Met adjacent to the pro-
tease cleavage site in pTP is not conserved, although the
cleavage site is present. An alternative Met is present 14
residues upstream. Whether alternative splicing occurs
during EDS infection remains to be determined. In the E4
region, both viruses contain two ORFs which have ho-
mology with each other (our unpublished results) and
with the Ad2 E4 34-kDa protein (Vrati et al., 1996b).
However, OAV has an additional 17.1-kDa ORF that is
missing in EDS. In both viruses there is a region of ;1 kb
between E4 and ORFs to the right. The prediction is that
this region of EDS may also contain a promoter(s), as
demonstrated for OAV. At the RHE OAV contains six
ORFs, of which four are closely related but of unknown
function (Xu et al., 1997). EDS contains two ORFs that
have homology with each other and to the four ORFs of
OAV. As the OAV genome (29.58 kb) is shorter than EDS
(33.7 kb), the VA RNA gene that lies to the right among
other EDS-specific ORFs is missing from OAV (Venktesh
et al., 1997).
Promoter function in other cells
Several of the transcripts defined in this study were
used to monitor OAV promoter function in OAV-infected
human cells (Khatri et al., 1997). A range of promoter
function was observed, depending on the cell type. In
MRC-5 lung fibroblasts, for example, all known promot-
ers were active (IVa2 was not examined). However, in
HepG2 liver carcinoma cells, none of the promoters was
active. The MLP was essentially inactive in all cell types,
probably because DNA replication did not occur (Khatri
et al., 1997). The characterisation of OAV promoters and
transcripts will facilitate additional studies in the assess-
ment of recombinant OAV as a potential gene therapy
vector.
MATERIALS AND METHODS
Virus and cell culture
OAV287 (OAV) (Peet et al., 1983; Boyle et al., 1994) was
propagated in CSL503 cells, a sheep foetal lung cell line,
as described (Boyle et al., 1994). CSL503 cells were
maintained in EMEM plus 10% FCS.
mRNA preparation and PCR
mRNA was prepared from OAV-infected (M.O.I. of 20)
or mock-infected CSL503 cells at various times between
12 and 48 h postinfection (pi) using Quickprep micro-
mRNA synthesis kits incorporating selection by oligo(dT)
(AMRAD/Pharmacia Biotech, Melbourne, Vic). mRNA
samples were treated with RNase-free DNase I (Boer-
hinger Mannheim, North Ryde, NSW) before use for
cDNA synthesis. cDNA was prepared using oligo(dT)15as
a primer for AMV reverse transcriptase (1st Strand cDNA
Synthesis Kit, Boehringer Mannheim). In some cases
priming with random hexamers was used. Oligonucleo-
tide primers for PCR were designed using the known
OAV sequence (Vrati et al., 1995, 1996a, b) and produced
using a DNA synthesiser (Applied Biosystems, Foster
City, CA). PCR was performed under commonly used
conditions (Sambrook et al., 1989) for 40 cycles using
annealing temperatures that were close to the melting
temperatures of particular primer pairs. The integrity and
yield of mRNA and cDNA preparations was monitored by
PCR amplification of glyceraldehyde-phosphate dehydro-
genase cDNA as described previously (Khatri et al.,
1997).
RLM–RACE (RNA ligation-mediated rapid amplification
of cDNA ends) (Schaeffer, 1995) together with RT–PCR
(collectively referred to here as RACE–PCR) was used to
map the 59 ends of various viral mRNAs. Briefly, mRNAs
were digested with alkaline phosphatase (Boehringer-
Mannheim) and intact mRNAs were decapped with to-
bacco acid pyrophosphatase (Epicentre Technologies,
Madison, WI) leaving only the full-length mRNAs with a 59
phosphate group. A single-stranded DNA oligonucleo-
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tide with an RNA base at its 39 end (sequence d(AGC TTA
AGC CTC TGA AGG TTAA) rA) (the anchor oligo) was
ligated to the 59 end of mRNAs using T4 RNA ligase
(Boehringer-Mannheim). cDNA was prepared from 24-h-
pi-polyadenylated mRNA using random primers (Pro-
mega, Madison, WI). Subsequent PCR amplification of
virus-specific transcripts was carried out using the 59
anchor oligo in conjunction with a 39 gene-specific
primer. In some cases a nested product was amplified by
using an internal 39 oligonucleotide. RNA molecules that
did not accept the anchor oligo, or cDNA molecules that
were not fully transcribed could not be amplified by
RACE–PCR. Fragments obtained by PCR or RACE–PCR
were blunt end-cloned into SmaI-cut, phosphatased
plasmid pGEM7Zf(2) (Promega, Madison, WI). Clones of
the expected size were identified by restriction endonu-
clease digestion and sequenced using an ABI Prism
Model 377 sequencer.
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